Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 17/20 | 0.59 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27195721 | 0.87 | SIRT6 (0.55) | TRPV1SIRT6NPY5RKDM4EALDH1A1 | |
| SCHEMBL27195706 | 0.81 | TRPV1 (0.58) | TRPV1 | |
| SCHEMBL30863450 | 0.75 | TRPV1 (0.57) | TRPV1NPY5RKDM4EALDH1A1MAPT | |
| SCHEMBL27195688 | 0.75 | TRPV1 (0.57) | TRPV1NPY5RKDM4EALDH1A1MAPT | |
| SCHEMBL30863479 | 0.74 | TRPV1 (0.50) | TRPV1NPY5RKDM4EALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL30863416 | 0.74 | HDAC3 (0.50) | SMN1; SMN2 | |
| SCHEMBL4019579 | 0.74 | TRPV1 (0.68) | TRPV1NPY5RKDM4EALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL27195728 | 0.74 | HDAC3 (0.50) | SMN1; SMN2 | |
| SCHEMBL27195758 | 0.74 | AURKA (0.53) | SIRT6 | |
| SCHEMBL3939874 | 0.73 | TRPV1 (0.49) | TRPV1NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | claimed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | claimed |